Compare Davita Inc (DVA) vs JetBlue Airways Corporation (JBLU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs JetBlue Airways Corporation — how do they compare? Davita Inc trades at $175.04 (market cap $11.28B), while JetBlue Airways Corporation trades at $3.91 (market cap $1.50B). The key difference: Davita Inc is far larger — about 7.5× JetBlue Airways Corporation's market cap, and Davita Inc is trading nearer its 52-week high, JetBlue Airways Corporation nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 113 Days and JetBlue Airways Corporation for 44 Days on average.
| DVA | JBLU | |
|---|---|---|
Market Cap | $11.28B | $1.50B |
Volume | 650,294 | 22,018,927 |
Sector | Health | Industrials |
52-Week High | $240.96 | $6.46 |
52-Week Low | $103.87 | $3.92 |
Typical Hold Time | 113 Days | 44 Days |
Enterprise Value | $24.00B | $8.86B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $177.02, down 1.87% on the day, showing mixed technical signals with a bearish moving average trend but neutral oscillators. Fundamentally, the company demonstrates strong earnings beats with Q2 2026 EPS of $4.02 exceeding expectations of $3.88, while revenue growth continues from $13.64B in 2025 to projected $14.0B in 2026. Recent developments include expanding value-based care partnerships with Humana, potentially benefiting over 10,000 Medicare Advantage members.
The outlook remains cautiously optimistic with 43% analyst buy ratings and a $235.67 consensus price target suggesting 33% upside. However, rising debt-to-asset ratios (65.55% in 2025) and margin pressures from Q2 2026 create headwinds. Key risks include regulatory changes in healthcare reimbursement and competitive pressures in dialysis services.
JetBlue (JBLU) trades at $3.92, down 2.73% on the day, reflecting ongoing challenges. The stock shows a bearish technical trend with key indicators mixed, while fundamentals reveal persistent losses with a negative net income margin of -9.32% and elevated debt levels. Recent news includes route expansion to Colombia but also capacity cuts due to fuel costs, highlighting operational pressures amid a difficult industry environment.
The outlook remains cautious with high debt and consistent earnings misses posing significant risks. However, the consensus price target of $5.89 suggests potential upside if operational improvements materialize. Investors face headwinds from fuel price volatility and competitive pressures, requiring careful monitoring of cost management and travel demand recovery for any sustained rebound.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About JetBlue Airways Corporation
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It carries over millions of customers with an average of more than 1,000 daily flights and served approximately 99 destinations in the United States, the Caribbean, and Latin America. The company currently operates Airbus A321, Airbus A320, and Embraer E190 aircraft types.
Read more on JBLU →
